美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

吉利德科学

150.89

+3.212.17%

盘前：150.31-0.5800-0.38%05:56 EDT

成交量：784.36万

成交额：11.76亿

市值：1,872.06亿

市盈率：-57.70

高：151.04

开：148.78

低：146.89

收：147.68

52周最高：157.29

52周最低：108.46

股本：12.41亿

流通股本：12.38亿

量比：1.58

换手率：0.63%

股息：3.22

股息率：2.13%

每股收益(TTM):-2.6150

每股收益(LYR):6.78

净资产收益率：-20.68%

总资产收益率：14.09%

市净率：15.83

市盈率(LYR):22.26

数据加载中...

总览公司新闻资讯公告

吉利德科学扩大六项免许可费自愿授权协议，力推每年一次HIV预防药Lenacapavir

吉利德科学携手巴西卫生部，共促Lenacapavir本地化生产新篇章

吉利德科学：持续探索与泛美卫生组织合作，助力各国准备好并扩大长效艾滋病预防措施的普及

吉利德科学公司高管在电话会议上表示，HIV药物市场的增长预计将在未来几个季度内回归至2%至3%的正常水平。

吉利德与泛美卫生组织就拉丁美洲和加勒比地区艾滋病预防药物获取问题达成一致

吉利德科学携手泛美卫生组织，加速拉美及加勒比地区HIV预防药物Lenacapavir的可及性

吉利德高管表示，未来几个季度HIV市场增长或将回归2%-3%常态水平

吉利德高管透露：周服HIV预防药物有望2027年第一季度上市

Assembly Biosciences有望获得高达2.8亿美元里程碑付款及美国境外特许权使用费

Assembly Biosciences旗下Gs-1179预计2026年底前将推进至生殖器疱疹二期临床试验阶段

Assembly Biosciences：吉利德独享HSV HPI项目临床开发与商业化权利

Assembly Biosciences行使与吉利德关于HSV解旋酶-引物酶抑制剂项目的美国利润分成选择权

吉利德科学(GILD)股票9月8日盘中下跌3.26%：释放什么信号？

TradingKey中文

异动解读｜吉利德科学盘中下跌3.18%，报148.27美元

异动解读｜吉利德科学盘前下跌3.47%，报146.39美元

美国食品药品监督管理局（FDA）批准吉利德治疗艾滋病的每日一次复方片剂

美国FDA批准吉利德科学Bixlenvo™上市：每日单片方案为病毒学抑制HIV成人患者提供新选择，涵盖复杂治疗方案人群

欧盟委员会扩大吉利德Trodelvy®在转移性三阴性乳腺癌一线治疗中的应用范围，覆盖所有PD-L1状态

吉利德科学：欧盟批准Trodelvy联合Keytruda用于一线PD-L1阳性转移性三阴性乳腺癌

异动解读｜吉利德科学盘中上涨3.07%，78亿美元收购Arcellx叠加Q2业绩超预期持续推升股价

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/hans/stock/GILD/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GILD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"吉利德科学","latestPrice":150.89,"timestamp":1789675200000,"preClose":147.68,"halted":0,"volume":7843596,"hourTrading":{"tag":"盘前","latestPrice":150.31,"preClose":150.89,"latestTime":"05:56 EDT","volume":942,"amount":140948.50212,"timestamp":1789725361690,"change":-0.58,"changeRate":-0.003844,"amplitude":0.008682},"delay":0,"changeRate":0.021736186348862267,"floatShares":1238162880,"shares":1240679623,"eps":-2.614993,"marketStatus":"盘前交易","change":3.21,"latestTime":"09-18 06:33:34 EDT","open":148.775,"high":151.04,"low":146.8901,"amount":1176206909.96556,"amplitude":0.028101,"askPrice":156,"askSize":5,"bidPrice":136.27,"bidSize":102,"shortable":3,"etf":0,"ttmEps":-2.614993,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":696056400000,"exchange":"NASDAQ","adjPreClose":150.89,"dividendRate":0.02134,"preHourTrading":{"tag":"盘前","latestPrice":150.31,"preClose":150.89,"latestTime":"05:56 EDT","volume":942,"amount":140948.50212,"timestamp":1789725361690,"change":-0.58,"changeRate":-0.003844,"amplitude":0.008682},"postHourTrading":{"tag":"盘后","latestPrice":150.44,"preClose":150.89,"latestTime":"19:57 EDT","volume":1633206,"amount":246433245.2189,"timestamp":1789689427464,"change":-0.45,"changeRate":-0.002982,"amplitude":0.003247},"volumeRatio":1.5771284290006742,"impliedVol":0.276,"impliedVolPercentile":0.128},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","floatShares":1238162880,"roa":"14.09%","roe":"-20.68%","lyrEps":6.78,"volumeRatio":1.5771284290006742,"shares":1240679623,"dividePrice":3.22,"high":151.04,"amplitude":0.028101,"preClose":147.68,"low":146.8901,"week52Low":108.4601,"pbRate":"15.83","psRate":"6.15","week52High":157.29,"institutionHeld":0.886,"latestPrice":150.89,"committee":0.906542,"eps":-2.614993,"divideRate":0.02134,"volume":7843596,"delay":0,"ttmEps":-2.614993,"open":148.775,"prevYearClose":122.74,"prevWeekClose":143.72,"prevMonthClose":146.34,"prevQuarterClose":126.34,"fiveDayClose":144.81,"twentyDayClose":147.6,"sixtyDayClose":125.05,"dividendPayoutRate":0.46193184575686363,"dividendFrequency":"Q","dividendGrowthYears":10,"dividendGrowthRate":0.025974025974025997,"fiveYearAvgDividendRate":0.03377732217604273},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GILD\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"GILD","amount":0.82,"announcedDate":"2026-08-04","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-29","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-29"},{"market":"US","date":"2026-08-04","symbol":"GILD","fiscalQuarterEnding":"2026/06","expectedEps":-7.07,"name":null,"time":"盘后","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":-6.75},{"date":"2026-06-15","symbol":"GILD","amount":0.82,"announcedDate":"2026-05-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-29","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-29"},{"market":"US","date":"2026-05-07","symbol":"GILD","fiscalQuarterEnding":"2026/03","expectedEps":1.89,"name":null,"time":"盘后","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":2.03},{"date":"2026-03-13","symbol":"GILD","amount":0.82,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-13","defaultRemindTime":1773408600000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-30","payableDate":"2026-03-13","currency":"USD","dateTimestamp":1773374400000,"payDate":"2026-03-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GILD\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-13","recordDate":"2016-12-15","paymentDate":"2016-12-29","value":0.47,"currency":"USD"},{"executeDate":"2017-03-14","recordDate":"2017-03-16","paymentDate":"2017-03-30","value":0.52,"currency":"USD"},{"executeDate":"2017-06-14","recordDate":"2017-06-16","paymentDate":"2017-06-29","value":0.52,"currency":"USD"},{"executeDate":"2017-09-14","recordDate":"2017-09-15","paymentDate":"2017-09-28","value":0.52,"currency":"USD"},{"executeDate":"2017-12-14","recordDate":"2017-12-15","paymentDate":"2017-12-28","value":0.52,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GILD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2258,"buy":0.5806,"hold":0.1935,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5806,"analysts":31,"updateTime":1784779200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GILD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GILD","date":"2026-09-16","current":-57.701875,"percent":0.00982,"low":-57.872228,"twenty":16.519278,"median":19.121152,"eighty":32.724704,"high":985.638037,"avg":85.983549,"sd":205.550448,"marketCap":181405439176},"quantilePoints":[{"date":"2021-09-24","current":17.291494,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":89258694033},{"date":"2021-10-01","current":16.652688,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85961175206},{"date":"2021-10-08","current":16.528813,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85321732392},{"date":"2021-10-15","current":16.426798,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84795132427},{"date":"2021-10-22","current":16.33207,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84306146745},{"date":"2021-10-29","current":11.012226,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":81424400000},{"date":"2021-11-05","current":11.251111,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":83190715179},{"date":"2021-11-12","current":11.447904,"twenty":5.893685,"median":17.235629,"eighty":51.009533,"marketCap":84645800064},{"date":"2021-11-19","current":11.653179,"twenty":5.897479,"median":17.235629,"eighty":51.009533,"marketCap":86163604126},{"date":"2021-11-26","current":11.921224,"twenty":5.918211,"median":17.235629,"eighty":51.009533,"marketCap":88145530090},{"date":"2021-12-03","current":11.800773,"twenty":6.026147,"median":17.235629,"eighty":51.009533,"marketCap":87254917790},{"date":"2021-12-10","current":11.917831,"twenty":6.210409,"median":17.235629,"eighty":51.009533,"marketCap":88120442420},{"date":"2021-12-17","current":12.250343,"twenty":6.275567,"median":17.235629,"eighty":51.009533,"marketCap":90579034123},{"date":"2021-12-23","current":12.296148,"twenty":6.286831,"median":17.235629,"eighty":51.009533,"marketCap":90917717674},{"date":"2021-12-31","current":12.318202,"twenty":6.311092,"median":17.235629,"eighty":51.009533,"marketCap":91080787532},{"date":"2022-01-07","current":12.089176,"twenty":6.331714,"median":17.2332,"eighty":50.998121,"marketCap":89387369777},{"date":"2022-01-14","current":12.175697,"twenty":6.376154,"median":17.2332,"eighty":50.998121,"marketCap":90027105373},{"date":"2022-01-21","current":11.622642,"twenty":6.392142,"median":17.2332,"eighty":50.998121,"marketCap":85937815092},{"date":"2022-01-28","current":11.682019,"twenty":6.427197,"median":17.2332,"eighty":50.998121,"marketCap":86376849324},{"date":"2022-02-04","current":12.876322,"twenty":6.478068,"median":17.2332,"eighty":50.998121,"marketCap":80155107055},{"date":"2022-02-11","current":12.507564,"twenty":6.506803,"median":17.2332,"eighty":50.998121,"marketCap":77859585210},{"date":"2022-02-18","current":12.302026,"twenty":6.55983,"median":17.2332,"eighty":50.998121,"marketCap":76580114018},{"date":"2022-02-25","current":12.311254,"twenty":6.578904,"median":17.2332,"eighty":50.998121,"marketCap":76637556570},{"date":"2022-03-04","current":12.46031,"twenty":6.599937,"median":17.2332,"eighty":50.998121,"marketCap":77565432746},{"date":"2022-03-11","current":11.6828,"twenty":6.635114,"median":17.2332,"eighty":50.998121,"marketCap":72725429992},{"date":"2022-03-18","current":11.968827,"twenty":6.678391,"median":17.2332,"eighty":50.998121,"marketCap":74505949140},{"date":"2022-03-25","current":11.884082,"twenty":6.698205,"median":17.2332,"eighty":50.998121,"marketCap":73978409872},{"date":"2022-04-01","current":12.037399,"twenty":8.02258,"median":17.2332,"eighty":50.998121,"marketCap":74932807962},{"date":"2022-04-08","current":12.567956,"twenty":8.716567,"median":17.2332,"eighty":50.998121,"marketCap":78235527670},{"date":"2022-04-14","current":12.471124,"twenty":8.90123,"median":17.2332,"eighty":50.998121,"marketCap":77632749929},{"date":"2022-04-22","current":12.55787,"twenty":9.141519,"median":17.2332,"eighty":50.998121,"marketCap":78172738322},{"date":"2022-04-29","current":16.504629,"twenty":9.361538,"median":17.2332,"eighty":50.998121,"marketCap":74518398265},{"date":"2022-05-06","current":16.996433,"twenty":10.809551,"median":17.239272,"eighty":50.998121,"marketCap":76738896748},{"date":"2022-05-13","current":17.327028,"twenty":11.245343,"median":17.247681,"eighty":50.998121,"marketCap":78231529751},{"date":"2022-05-20","current":17.735409,"twenty":11.419063,"median":17.289789,"eighty":50.998121,"marketCap":80075370520},{"date":"2022-05-27","current":18.002107,"twenty":11.443493,"median":17.319427,"eighty":50.998121,"marketCap":81279511430},{"date":"2022-06-03","current":17.627063,"twenty":11.598891,"median":17.34736,"eighty":50.998121,"marketCap":79586188275},{"date":"2022-06-10","current":16.874197,"twenty":11.674743,"median":17.353688,"eighty":50.998121,"marketCap":76186998831},{"date":"2022-06-17","current":16.260236,"twenty":11.693895,"median":17.353688,"eighty":50.998121,"marketCap":73414966111},{"date":"2022-06-24","current":17.524273,"twenty":11.796701,"median":17.385368,"eighty":51.009533,"marketCap":79122092299},{"date":"2022-07-01","current":17.32425,"twenty":11.863803,"median":17.393509,"eighty":51.009533,"marketCap":78218986617},{"date":"2022-07-08","current":17.457598,"twenty":11.905616,"median":17.41294,"eighty":51.009533,"marketCap":78821057072},{"date":"2022-07-15","current":17.390924,"twenty":11.935322,"median":17.41294,"eighty":51.009533,"marketCap":78520021844},{"date":"2022-07-22","current":16.890865,"twenty":11.980941,"median":17.41294,"eighty":51.009533,"marketCap":76262257638},{"date":"2022-07-29","current":16.599165,"twenty":12.028097,"median":17.41294,"eighty":51.009533,"marketCap":74945228518},{"date":"2022-08-05","current":18.52212,"twenty":12.086156,"median":17.427039,"eighty":51.009533,"marketCap":76626008538},{"date":"2022-08-12","current":19.074694,"twenty":12.171909,"median":17.456661,"eighty":51.009533,"marketCap":78912011126},{"date":"2022-08-19","current":19.795752,"twenty":12.222347,"median":17.478521,"eighty":51.009533,"marketCap":81895025523},{"date":"2022-08-26","current":18.895945,"twenty":12.254415,"median":17.529437,"eighty":51.009533,"marketCap":78172524363},{"date":"2022-09-02","current":19.335245,"twenty":12.287819,"median":17.577057,"eighty":51.009533,"marketCap":79989907085},{"date":"2022-09-09","current":19.777574,"twenty":12.303022,"median":17.627063,"eighty":51.009533,"marketCap":81819823480},{"date":"2022-09-16","current":19.874523,"twenty":12.328536,"median":17.735409,"eighty":51.009533,"marketCap":82220901046},{"date":"2022-09-23","current":19.044398,"twenty":12.37249,"median":17.877092,"eighty":51.009533,"marketCap":78786674386},{"date":"2022-09-30","current":18.689929,"twenty":12.440381,"median":18.002107,"eighty":51.009533,"marketCap":77320234535},{"date":"2022-10-07","current":19.477638,"twenty":12.472434,"median":18.174606,"eighty":51.009533,"marketCap":80578989760},{"date":"2022-10-14","current":20.047213,"twenty":12.542538,"median":18.389663,"eighty":51.009533,"marketCap":82935320460},{"date":"2022-10-21","current":20.538017,"twenty":12.806741,"median":18.504662,"eighty":51.009533,"marketCap":84965775639},{"date":"2022-10-28","current":29.80037,"twenty":13.013399,"median":18.615892,"eighty":51.009533,"marketCap":99354433322},{"date":"2022-11-04","current":30.22374,"twenty":13.251735,"median":18.662662,"eighty":51.009533,"marketCap":100765950507},{"date":"2022-11-11","current":30.780513,"twenty":13.37445,"median":18.717011,"eighty":51.009533,"marketCap":102622231397},{"date":"2022-11-18","current":31.45767,"twenty":13.431735,"median":18.843409,"eighty":51.009533,"marketCap":104879870318},{"date":"2022-11-25","current":32.450832,"twenty":13.459519,"median":18.879888,"eighty":51.009533,"marketCap":108191074069},{"date":"2022-12-02","current":33.4929,"twenty":13.504605,"median":18.899024,"eighty":51.009533,"marketCap":111665329520},{"date":"2022-12-09","current":33.09413,"twenty":13.606687,"median":18.972334,"eighty":51.009533,"marketCap":110335831044},{"date":"2022-12-16","current":32.638931,"twenty":13.64752,"median":19.040589,"eighty":51.009533,"marketCap":108818195992},{"date":"2022-12-23","current":31.882773,"twenty":13.702003,"median":19.108021,"eighty":51.009533,"marketCap":106297165863},{"date":"2022-12-30","current":32.296591,"twenty":13.772637,"median":19.194795,"eighty":51.009533,"marketCap":107676834093},{"date":"2023-01-06","current":33.135512,"twenty":13.805022,"median":19.238296,"eighty":51.009533,"marketCap":110473797867},{"date":"2023-01-13","current":32.454594,"twenty":13.873802,"median":19.29283,"eighty":51.009533,"marketCap":108203616508},{"date":"2023-01-20","current":31.228189,"twenty":13.90331,"median":19.320096,"eighty":51.009533,"marketCap":104114781573},{"date":"2023-01-27","current":31.499051,"twenty":13.995449,"median":19.384392,"eighty":51.009533,"marketCap":105017837141},{"date":"2023-02-03","current":22.946755,"twenty":14.041486,"median":19.450119,"eighty":51.009533,"marketCap":105371500000},{"date":"2023-02-10","current":23.544186,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":108114900000},{"date":"2023-02-17","current":23.017361,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105695720000},{"date":"2023-02-24","current":21.905815,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":100591501721},{"date":"2023-03-03","current":22.017164,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":101102814834},{"date":"2023-03-10","current":21.59078,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99144859743},{"date":"2023-03-17","current":20.996015,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":96413699455},{"date":"2023-03-24","current":21.756377,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99905284240},{"date":"2023-03-31","current":22.564083,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":103614267917},{"date":"2023-04-06","current":22.749012,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":104463462833},{"date":"2023-04-14","current":22.645669,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":103988912733},{"date":"2023-04-21","current":23.031845,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105762231528},{"date":"2023-04-28","current":18.688623,"twenty":14.055938,"median":19.442338,"eighty":51.020944,"marketCap":104338581228},{"date":"2023-05-05","current":17.542922,"twenty":14.055938,"median":19.3806,"eighty":51.020944,"marketCap":97942133140},{"date":"2023-05-12","current":17.583137,"twenty":14.055938,"median":19.319381,"eighty":51.020944,"marketCap":98166656624},{"date":"2023-05-19","current":17.473662,"twenty":14.050438,"median":19.278218,"eighty":51.032356,"marketCap":97555453806},{"date":"2023-05-26","current":17.348547,"twenty":14.044939,"median":19.233751,"eighty":51.043768,"marketCap":96856936300},{"date":"2023-06-02","current":17.026822,"twenty":14.044939,"median":19.162011,"eighty":51.043768,"marketCap":95060748428},{"date":"2023-06-08","current":16.997778,"twenty":14.044939,"median":19.104641,"eighty":51.043768,"marketCap":94898592579},{"date":"2023-06-16","current":17.650163,"twenty":14.039759,"median":19.040589,"eighty":51.200274,"marketCap":98540862431},{"date":"2023-06-23","current":17.45132,"twenty":14.038033,"median":18.973525,"eighty":51.252442,"marketCap":97430718537},{"date":"2023-06-30","current":16.982138,"twenty":14.036306,"median":18.920182,"eighty":51.304611,"marketCap":94811277890},{"date":"2023-07-07","current":17.033525,"twenty":14.036306,"median":18.886384,"eighty":51.304611,"marketCap":95098169009},{"date":"2023-07-14","current":17.138532,"twenty":14.036306,"median":18.848464,"eighty":51.304611,"marketCap":95684424773},{"date":"2023-07-21","current":17.860178,"twenty":14.036306,"median":18.770739,"eighty":51.304611,"marketCap":99713373958},{"date":"2023-07-28","current":17.093848,"twenty":14.036306,"median":18.679091,"eighty":51.304611,"marketCap":95434954235},{"date":"2023-08-04","current":17.179531,"twenty":14.036306,"median":18.633127,"eighty":51.304611,"marketCap":94212548600},{"date":"2023-08-11","current":18.176723,"twenty":14.036306,"median":18.52212,"eighty":51.304611,"marketCap":99681148240},{"date":"2023-08-18","current":17.381491,"twenty":14.036306,"median":18.429012,"eighty":51.304611,"marketCap":95320098004},{"date":"2023-08-25","current":17.342866,"twenty":14.036306,"median":18.328953,"eighty":51.304611,"marketCap":95108275564},{"date":"2023-09-01","current":17.376947,"twenty":14.036306,"median":18.1949,"eighty":51.304611,"marketCap":95295177717},{"date":"2023-09-08","current":16.799836,"twenty":14.036306,"median":18.174606,"eighty":51.304611,"marketCap":92130301260},{"date":"2023-09-15","current":17.576891,"twenty":14.036306,"median":18.052169,"eighty":51.304611,"marketCap":96391670348},{"date":"2023-09-22","current":17.102024,"twenty":14.036306,"median":17.993772,"eighty":51.304611,"marketCap":93787500350},{"date":"2023-09-29","current":17.136105,"twenty":14.036306,"median":17.876807,"eighty":51.304611,"marketCap":93974402503},{"date":"2023-10-06","current":16.972515,"twenty":14.036306,"median":17.771527,"eighty":51.304611,"marketCap":93077272169},{"date":"2023-10-13","current":17.440566,"twenty":14.036306,"median":17.722305,"eighty":51.304611,"marketCap":95644061736},{"date":"2023-10-19","current":18.101744,"twenty":14.036306,"median":17.689975,"eighty":51.304611,"marketCap":99269963503},{"date":"2023-10-27","current":17.835909,"twenty":14.029482,"median":17.676863,"eighty":51.032356,"marketCap":97812126710},{"date":"2023-11-03","current":18.45619,"twenty":14.029482,"median":17.650163,"eighty":33.471833,"marketCap":101213745894},{"date":"2023-11-10","current":15.89997,"twenty":14.029482,"median":17.641227,"eighty":33.09714,"marketCap":93428221287},{"date":"2023-11-17","current":15.802424,"twenty":14.029482,"median":17.615533,"eighty":32.981271,"marketCap":92855042015},{"date":"2023-11-24","current":15.984792,"twenty":14.029482,"median":17.59511,"eighty":32.559177,"marketCap":93926638045},{"date":"2023-12-01","current":16.243501,"twenty":14.029482,"median":17.57082,"eighty":32.289819,"marketCap":95446809157},{"date":"2023-12-08","current":16.550982,"twenty":14.031188,"median":17.55419,"eighty":32.133321,"marketCap":97253569904},{"date":"2023-12-15","current":17.341951,"twenty":14.031188,"median":17.52836,"eighty":32.07012,"marketCap":101901306173},{"date":"2023-12-22","current":16.737591,"twenty":14.031188,"median":17.504184,"eighty":31.887287,"marketCap":98350086772},{"date":"2023-12-29","current":17.206235,"twenty":14.029482,"median":17.486007,"eighty":31.764,"marketCap":101103839360},{"date":"2024-01-05","current":17.914503,"twenty":14.027776,"median":17.48476,"eighty":31.6075,"marketCap":105265619289},{"date":"2024-01-12","current":18.107474,"twenty":14.027776,"median":17.48476,"eighty":31.532333,"marketCap":106399517414},{"date":"2024-01-19","current":18.321651,"twenty":14.024373,"median":17.483513,"eighty":31.465946,"marketCap":107658019728},{"date":"2024-01-26","current":17.013264,"twenty":14.027776,"median":17.475784,"eighty":31.443073,"marketCap":99969941235},{"date":"2024-02-02","current":16.574308,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":97390634513},{"date":"2024-02-09","current":16.232638,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91957891851},{"date":"2024-02-16","current":16.138057,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91422093836},{"date":"2024-02-23","current":16.008284,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":90686929118},{"date":"2024-03-01","current":15.855313,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":89820349813},{"date":"2024-03-08","current":16.198369,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91763758214},{"date":"2024-03-15","current":16.319318,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":92448934253},{"date":"2024-03-22","current":16.073021,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91053666683},{"date":"2024-03-28","current":16.055429,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":90954004714},{"date":"2024-04-05","current":15.309217,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":86726715023},{"date":"2024-04-12","current":15.111111,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":85604442650},{"date":"2024-04-19","current":14.563017,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":82499489086},{"date":"2024-04-26","current":167.813786,"twenty":14.029482,"median":17.45909,"eighty":31.35376,"marketCap":81389686406},{"date":"2024-05-03","current":167.968051,"twenty":14.029482,"median":17.475896,"eighty":31.454751,"marketCap":81464504564},{"date":"2024-05-10","current":165.891135,"twenty":14.029482,"median":17.490666,"eighty":31.502061,"marketCap":80457200237},{"date":"2024-05-17","current":174.305702,"twenty":14.043532,"median":17.524273,"eighty":31.57906,"marketCap":84538265441},{"date":"2024-05-24","current":169.975478,"twenty":14.043532,"median":17.54896,"eighty":31.623197,"marketCap":82438106839},{"date":"2024-05-31","current":164.60675,"twenty":14.10774,"median":17.565264,"eighty":31.836928,"marketCap":79834273632},{"date":"2024-06-07","current":164.015933,"twenty":14.265245,"median":17.579161,"eighty":32.047548,"marketCap":79547727394},{"date":"2024-06-14","current":163.27099,"twenty":14.274228,"median":17.606597,"eighty":32.082158,"marketCap":79186429964},{"date":"2024-06-21","current":175.935023,"twenty":14.272576,"median":17.621828,"eighty":32.181475,"marketCap":85328486284},{"date":"2024-06-28","current":176.808405,"twenty":14.267619,"median":17.642004,"eighty":32.289819,"marketCap":85752076375},{"date":"2024-07-05","current":171.054361,"twenty":14.267619,"median":17.658975,"eighty":32.499738,"marketCap":82961365187},{"date":"2024-07-12","current":179.736802,"twenty":14.267619,"median":17.687689,"eighty":32.981271,"marketCap":87172349033},{"date":"2024-07-15","current":179.711114,"twenty":14.267619,"median":17.696211,"eighty":33.038453,"marketCap":87159890501},{"date":"2024-08-02","current":196.485179,"twenty":14.529265,"median":17.810595,"eighty":33.095635,"marketCap":95295311956},{"date":"2024-08-09","current":89.28743,"twenty":14.761123,"median":17.860178,"eighty":33.429699,"marketCap":94108951402},{"date":"2024-08-16","current":87.810922,"twenty":15.064446,"median":17.910429,"eighty":56.284205,"marketCap":92552711301},{"date":"2024-08-23","current":89.653604,"twenty":15.441554,"median":17.994613,"eighty":57.705461,"marketCap":94494898947},{"date":"2024-08-30","current":93.846889,"twenty":15.739388,"median":18.052169,"eighty":58.207525,"marketCap":98914620835},{"date":"2024-09-06","current":93.043668,"twenty":15.813085,"median":18.107474,"eighty":58.39978,"marketCap":98068026220},{"date":"2024-09-13","current":98.229166,"twenty":15.851395,"median":18.176723,"eighty":59.168901,"marketCap":103533541455},{"date":"2024-09-20","current":99.10326,"twenty":15.88894,"median":18.219893,"eighty":59.37255,"marketCap":104454835595},{"date":"2024-09-27","current":98.087422,"twenty":15.920691,"median":18.287258,"eighty":59.81346,"marketCap":103384142406},{"date":"2024-10-04","current":99.422185,"twenty":15.979621,"median":18.356937,"eighty":60.090264,"marketCap":104790983457},{"date":"2024-10-11","current":100.012789,"twenty":16.007608,"median":18.435741,"eighty":60.321593,"marketCap":105413479498},{"date":"2024-10-18","current":103.190235,"twenty":16.047512,"median":18.510381,"eighty":60.845545,"marketCap":108762508196},{"date":"2024-10-25","current":104.867549,"twenty":16.062334,"median":18.540053,"eighty":61.800519,"marketCap":110530396951},{"date":"2024-10-31","current":104.288758,"twenty":16.062334,"median":18.540053,"eighty":63.846895,"marketCap":109920350831},{"date":"2024-11-08","current":968.122222,"twenty":16.060766,"median":18.539019,"eighty":65.503766,"marketCap":121983400000},{"date":"2024-11-15","current":911.059905,"twenty":16.060766,"median":18.539019,"eighty":67.314857,"marketCap":114793548088},{"date":"2024-11-22","current":887.816058,"twenty":16.060766,"median":18.539019,"eighty":87.499083,"marketCap":111864823324},{"date":"2024-11-29","current":915.708675,"twenty":16.060766,"median":18.539019,"eighty":88.564531,"marketCap":115379293041},{"date":"2024-12-06","current":923.720384,"twenty":16.060766,"median":18.539019,"eighty":90.934033,"marketCap":116388768385},{"date":"2024-12-13","current":913.730475,"twenty":16.060766,"median":18.539019,"eighty":93.40748,"marketCap":115130039869},{"date":"2024-12-20","current":900.971087,"twenty":16.060766,"median":18.539019,"eighty":95.961249,"marketCap":113522356914},{"date":"2024-12-27","current":933.809203,"twenty":16.060766,"median":18.539019,"eighty":98.094509,"marketCap":117659959559},{"date":"2025-01-03","current":908.784976,"twenty":16.060766,"median":18.539019,"eighty":98.88828,"marketCap":114506906941},{"date":"2025-01-10","current":881.683639,"twenty":16.059197,"median":18.537985,"eighty":99.141058,"marketCap":111092138492},{"date":"2025-01-17","current":906.510046,"twenty":16.059197,"median":18.537985,"eighty":99.880493,"marketCap":114220265794},{"date":"2025-01-24","current":919.071615,"twenty":16.059197,"median":18.537985,"eighty":100.438024,"marketCap":115803023432},{"date":"2025-01-31","current":958.93234,"twenty":16.059197,"median":18.537985,"eighty":102.332679,"marketCap":120825474836},{"date":"2025-02-07","current":969.713529,"twenty":16.09178,"median":18.615892,"eighty":104.116302,"marketCap":122183904620},{"date":"2025-02-14","current":275.113188,"twenty":16.111578,"median":18.662662,"eighty":105.609347,"marketCap":132054330207},{"date":"2025-02-21","current":285.680484,"twenty":16.147709,"median":18.689929,"eighty":162.793199,"marketCap":137126632245},{"date":"2025-02-28","current":290.769403,"twenty":16.147709,"median":18.808017,"eighty":164.216297,"marketCap":139569313325},{"date":"2025-03-07","current":301.06241,"twenty":16.143392,"median":18.87176,"eighty":165.27463,"marketCap":144509957034},{"date":"2025-03-14","current":294.083284,"twenty":16.164977,"median":18.897485,"eighty":166.913912,"marketCap":141159976127},{"date":"2025-03-21","current":274.676641,"twenty":16.17325,"median":18.953832,"eighty":167.968051,"marketCap":131844787583},{"date":"2025-03-28","current":288.401392,"twenty":16.17325,"median":19.023685,"eighty":168.716781,"marketCap":138432668251},{"date":"2025-04-04","current":291.592591,"twenty":16.17325,"median":19.104641,"eighty":171.054361,"marketCap":139964443908},{"date":"2025-04-11","current":263.079356,"twenty":16.173436,"median":19.194795,"eighty":173.515242,"marketCap":126278090686},{"date":"2025-04-17","current":272.389631,"twenty":16.173436,"median":19.238296,"eighty":174.142022,"marketCap":130747023108},{"date":"2025-04-25","current":22.184451,"twenty":16.17325,"median":19.285524,"eighty":176.243276,"marketCap":132330248884},{"date":"2025-05-02","current":21.578375,"twenty":16.17325,"median":19.297177,"eighty":176.243276,"marketCap":128715008924},{"date":"2025-05-09","current":20.470089,"twenty":16.17325,"median":19.297177,"eighty":176.243276,"marketCap":122104082517},{"date":"2025-05-16","current":20.924702,"twenty":16.17325,"median":19.309817,"eighty":176.243276,"marketCap":124815848001},{"date":"2025-05-23","current":22.259345,"twenty":16.17325,"median":19.375544,"eighty":176.243276,"marketCap":132776994375},{"date":"2025-05-30","current":23.170656,"twenty":16.17325,"median":19.403352,"eighty":176.243276,"marketCap":138212964634},{"date":"2025-06-06","current":23.035107,"twenty":16.17325,"median":19.46767,"eighty":176.243276,"marketCap":137404410705},{"date":"2025-06-13","current":23.366682,"twenty":16.17325,"median":19.52123,"eighty":176.243276,"marketCap":139382258008},{"date":"2025-06-20","current":22.522103,"twenty":16.167278,"median":19.629121,"eighty":176.258689,"marketCap":134344345068},{"date":"2025-06-27","current":22.442859,"twenty":16.167278,"median":19.72304,"eighty":176.258689,"marketCap":133871652002},{"date":"2025-07-03","current":23.304121,"twenty":16.167278,"median":19.777574,"eighty":176.258689,"marketCap":139009079271},{"date":"2025-07-11","current":23.885942,"twenty":16.167278,"median":19.874523,"eighty":176.258689,"marketCap":142479641519},{"date":"2025-07-18","current":22.688934,"twenty":16.167278,"median":20.047213,"eighty":176.258689,"marketCap":135339488364},{"date":"2025-07-25","current":23.606501,"twenty":16.167278,"median":20.135073,"eighty":176.258689,"marketCap":140812776497},{"date":"2025-08-01","current":23.416731,"twenty":16.193531,"median":20.515968,"eighty":176.258689,"marketCap":139680800997},{"date":"2025-08-08","current":21.73673,"twenty":16.230379,"median":20.924702,"eighty":176.258689,"marketCap":137180503463},{"date":"2025-08-15","current":23.400545,"twenty":16.265509,"median":21.375144,"eighty":176.258689,"marketCap":147680839142},{"date":"2025-08-22","current":22.834308,"twenty":16.329624,"median":21.49301,"eighty":176.258689,"marketCap":144107315224},{"date":"2025-08-29","current":22.130443,"twenty":16.387413,"median":21.593495,"eighty":176.258689,"marketCap":139665226464},{"date":"2025-09-05","current":22.171731,"twenty":16.4349,"median":21.646285,"eighty":176.274101,"marketCap":139925795917},{"date":"2025-09-12","current":23.172477,"twenty":16.509435,"median":21.73673,"eighty":176.258689,"marketCap":146241503119},{"date":"2025-09-19","current":22.33885,"twenty":16.547758,"median":21.802614,"eighty":176.258689,"marketCap":140980481795},{"date":"2025-09-26","current":21.821765,"twenty":16.572129,"median":22.017164,"eighty":176.258689,"marketCap":137717159606},{"date":"2025-10-03","current":21.737223,"twenty":16.611295,"median":22.028027,"eighty":176.258689,"marketCap":137183612632},{"date":"2025-10-10","current":22.952274,"twenty":16.651672,"median":22.107199,"eighty":176.258689,"marketCap":144851799373},{"date":"2025-10-17","current":23.170511,"twenty":16.731298,"median":22.14224,"eighty":176.258689,"marketCap":146229095050},{"date":"2025-10-24","current":23.738714,"twenty":16.778677,"median":22.171731,"eighty":176.258689,"marketCap":149815027037},{"date":"2025-10-31","current":18.120983,"twenty":16.795866,"median":22.184451,"eighty":176.258689,"marketCap":146961171131},{"date":"2025-11-07","current":18.898002,"twenty":16.795866,"median":22.144649,"eighty":176.258689,"marketCap":153262800000},{"date":"2025-11-14","current":19.153279,"twenty":16.795866,"median":22.11668,"eighty":176.258689,"marketCap":155333088799},{"date":"2025-11-21","current":19.121152,"twenty":16.795866,"median":22.040002,"eighty":176.258689,"marketCap":155072546078},{"date":"2025-11-28","current":19.254246,"twenty":16.795866,"median":21.968279,"eighty":176.258689,"marketCap":156151937350},{"date":"2025-12-05","current":18.758586,"twenty":16.795866,"median":21.821765,"eighty":176.258689,"marketCap":152132135372},{"date":"2025-12-12","current":18.848845,"twenty":16.795866,"median":21.756377,"eighty":176.258689,"marketCap":152864136349},{"date":"2025-12-19","current":18.582658,"twenty":16.795866,"median":21.664107,"eighty":176.258689,"marketCap":150705353805},{"date":"2025-12-26","current":19.22518,"twenty":16.795866,"median":21.623369,"eighty":176.258689,"marketCap":155916208222},{"date":"2026-01-02","current":18.776944,"twenty":16.795866,"median":21.579916,"eighty":176.258689,"marketCap":152281016927},{"date":"2026-01-09","current":18.460273,"twenty":16.795866,"median":21.456002,"eighty":176.258689,"marketCap":149712810107},{"date":"2026-01-16","current":18.550532,"twenty":16.795866,"median":21.131806,"eighty":176.258689,"marketCap":150444811084},{"date":"2026-01-23","current":20.061988,"twenty":16.795866,"median":20.904605,"eighty":176.258689,"marketCap":162702725760},{"date":"2026-01-30","current":21.348562,"twenty":16.795866,"median":20.79477,"eighty":176.258689,"marketCap":173136841389},{"date":"2026-02-06","current":22.85084,"twenty":16.795866,"median":20.79477,"eighty":174.722564,"marketCap":185320315287},{"date":"2026-02-13","current":22.1325,"twenty":16.795866,"median":20.79477,"eighty":173.804449,"marketCap":188347573567},{"date":"2026-02-20","current":22.031904,"twenty":16.795866,"median":20.79477,"eighty":172.268409,"marketCap":187491504627},{"date":"2026-02-27","current":20.972859,"twenty":16.795866,"median":20.79477,"eighty":169.624219,"marketCap":178479029310},{"date":"2026-03-06","current":21.172712,"twenty":16.795866,"median":20.79477,"eighty":168.328001,"marketCap":180179775433},{"date":"2026-03-13","current":21.182923,"twenty":16.795866,"median":20.79477,"eighty":167.61653,"marketCap":180266674870},{"date":"2026-03-20","current":20.584824,"twenty":16.795866,"median":20.611082,"eighty":165.952785,"marketCap":175176850706},{"date":"2026-03-27","current":19.964567,"twenty":16.795866,"median":20.470089,"eighty":164.868764,"marketCap":169898469139},{"date":"2026-04-02","current":20.46339,"twenty":16.795866,"median":20.259289,"eighty":164.031346,"marketCap":174143448423},{"date":"2026-04-10","current":20.72447,"twenty":16.795866,"median":20.244608,"eighty":117.698348,"marketCap":176365235827},{"date":"2026-04-17","current":20.208145,"twenty":16.795866,"median":20.209417,"eighty":104.84865,"marketCap":171971309901},{"date":"2026-04-24","current":19.491999,"twenty":16.795866,"median":20.110836,"eighty":103.06739,"marketCap":165876909817},{"date":"2026-05-01","current":19.083606,"twenty":16.795866,"median":20.053272,"eighty":101.446774,"marketCap":162401488180},{"date":"2026-05-08","current":18.055363,"twenty":16.795866,"median":20.001768,"eighty":100.029326,"marketCap":166398223062},{"date":"2026-05-15","current":17.790985,"twenty":16.795866,"median":19.879972,"eighty":99.16232,"marketCap":163961717560},{"date":"2026-05-22","current":17.580823,"twenty":16.795866,"median":19.795752,"eighty":98.985139,"marketCap":162024868557},{"date":"2026-05-29","current":18.351416,"twenty":16.791895,"median":19.747277,"eighty":98.092147,"marketCap":169126648236},{"date":"2026-06-05","current":17.402994,"twenty":16.795866,"median":19.677595,"eighty":95.725008,"marketCap":160385996323},{"date":"2026-06-12","current":16.957075,"twenty":16.779935,"median":19.565498,"eighty":93.346057,"marketCap":156276400040},{"date":"2026-06-18","current":16.900493,"twenty":16.778677,"median":19.477638,"eighty":91.321469,"marketCap":155754940693},{"date":"2026-06-26","current":16.683595,"twenty":16.763038,"median":19.378819,"eighty":88.47476,"marketCap":153756013196},{"date":"2026-07-02","current":16.970547,"twenty":16.763038,"median":19.32767,"eighty":87.461284,"marketCap":156400557027},{"date":"2026-07-10","current":18.165504,"twenty":16.763038,"median":19.252716,"eighty":33.559111,"marketCap":167413281810},{"date":"2026-07-17","current":18.362193,"twenty":16.763038,"median":19.215075,"eighty":33.11294,"marketCap":169225973826},{"date":"2026-07-24","current":17.629322,"twenty":16.763038,"median":19.127485,"eighty":33.032434,"marketCap":162471833711},{"date":"2026-07-31","current":17.685904,"twenty":16.770136,"median":19.121152,"eighty":32.724704,"marketCap":162993293058},{"date":"2026-08-07","current":-50.080411,"twenty":16.770136,"median":19.121152,"eighty":32.724704,"marketCap":162260531583},{"date":"2026-08-14","current":-52.866483,"twenty":16.740781,"median":19.121152,"eighty":32.724704,"marketCap":171287405111},{"date":"2026-08-21","current":-54.894805,"twenty":16.668037,"median":19.121152,"eighty":32.724704,"marketCap":177859167433},{"date":"2026-08-28","current":-56.969051,"twenty":16.618247,"median":19.121152,"eighty":32.724704,"marketCap":184579724373},{"date":"2026-09-04","current":-57.872228,"twenty":16.559862,"median":19.121152,"eighty":32.724704,"marketCap":187506018539},{"date":"2026-09-11","current":-55.419107,"twenty":16.541929,"median":19.121152,"eighty":32.724704,"marketCap":179557905995},{"date":"2026-09-16","current":-55.989333,"twenty":16.519278,"median":19.121152,"eighty":32.724704,"marketCap":181405439176}],"updateTime":1789709023330},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GILD\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1164691459","title":"吉利德科学扩大六项免许可费自愿授权协议，力推每年一次HIV预防药Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=1164691459","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164691459?lang=zh_cn&edition=fundamental","pubTime":"2026-09-16 20:31","pubTimestamp":1789561872,"startTime":"0","endTime":"0","summary":"吉利德科学宣布，扩大其六项免许可费的自愿授权协议，覆盖其每年仅需注射一次的HIV预防药物Lenacapavir。此举旨在拓宽药物可及性，助力全球抗击艾滋病疫情。通过这一系列协议，吉利德希望加快该长效预防方案在中低收入国家的推广，以应对持续存在的公共卫生挑战。该举措不仅彰显了公司在全球健康公平方面的承诺，也为实现2030年终结艾滋病流行的目标注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU0289739699.SGD","GILD","BK4578","BIB","LU0889565916.HKD","IE00B7SZLL34.SGD","BK4550","LU1430594728.SGD","LU1674673428.USD","LU2089984988.USD","LU0823416689.USD","LU2324357040.USD","LU1023059063.AUD","LU1585245621.USD","TMED","LU1037948541.HKD","LU1066053197.SGD","BK4139","MEDI","SG9999015986.USD","IE00B19Z3B42.SGD","LU1934455277.USD","LU0965509101.SGD","LU2087621335.USD","BK4568","IBBQ","IE00BSNM7G36.USD","LU2468319806.SGD","SG9999015978.USD","LU0965509010.AUD","LU1057294990.SGD","LU0109394709.USD","IE0002270589.USD","BK4532","LU0859254822.USD","LU1066051498.USD","BK4585","BMED","LU0861579265.USD","LU2357627491.SGD","SG9999015945.SGD","LU0965509283.SGD","LU0234570918.USD","IE00B19Z3581.USD","BBH","LU0965508806.USD","LU0320765992.SGD","IBB","LU1571399168.USD","IE00BKVL7J92.USD","LU1778281490.HKD","LU2112291526.USD","IE00B3T34201.USD","LU1934455194.USD","BK4566","LU0122379950.USD","LU1674673691.USD","LU1839511570.USD","TBXU","IE00BZ1G4Q59.USD","LU0114720955.EUR","LU1037948897.HKD","SG9999015952.SGD","BK4583","BK4588","LU0058720904.USD","LU1061106388.HKD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120765496","title":"吉利德科学携手巴西卫生部，共促Lenacapavir本地化生产新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=1120765496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120765496?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485331,"startTime":"0","endTime":"0","summary":"吉利德科学公司近日透露，正积极与巴西卫生部探索合作良机，旨在助力该国实现Lenacapavir药物的本土生产愿景。这一举措，无疑为巴西医药产业自主化进程注入了强劲动力。据悉，双方的洽谈聚焦于如何深化协作，以切实推进巴西卫生部既定的战略目标——即构建并强化Lenacapavir的本地制造能力。Lenacapavir，作为一款备受瞩目的长效抗逆转录病毒药物，其本地化生产若能落地，对巴西乃至更广泛地区的HIV防治工作意义深远。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","LU1571399168.USD","LU0234570918.USD","BK4566","TBXU","LU0889565916.HKD","LU0058720904.USD","LU0882574055.USD","LU1934455277.USD","LU2087621335.USD","LU1934455194.USD","IBBQ","IE00B7SZLL34.SGD","LU0122379950.USD","GILD","LU0965509010.AUD","BIB","BMED","BK4550","LU1674673428.USD","LU2089984988.USD","LU0320765992.SGD","BK4588","LU0109394709.USD","LU0289739699.SGD","LU2324357040.USD","LU2112291526.USD","BK4139","LU1037948541.HKD","BBH","BK4568","LU0965509283.SGD","LU1839511570.USD","SG9999015952.SGD","LU1066053197.SGD","SG9999015945.SGD","TMED","LU1057294990.SGD","LU1023059063.AUD","IE00B19Z3581.USD","IE00BSNM7G36.USD","BK4578","BK4583","LU1674673691.USD","LU1061106388.HKD","IE00B19Z3B42.SGD","LU1066051498.USD","LU0965509101.SGD","LU2468319806.SGD","LU1934455863.HKD","LU0823416689.USD","LU1778281490.HKD","LU1037948897.HKD","LU1430594728.SGD","IE00B3T34201.USD","SG9999015978.USD","BK4532","IE0002270589.USD","LU0965508806.USD","LU1585245621.USD","BK4585","LU0114720955.EUR","LU0861579265.USD","IBB","LU0859254822.USD","MEDI","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU2357627491.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158863992","title":"吉利德科学：持续探索与泛美卫生组织合作，助力各国准备好并扩大长效艾滋病预防措施的普及","url":"https://stock-news.laohu8.com/highlight/detail?id=1158863992","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158863992?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485330,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）宣布，将继续探索与泛美卫生组织（PAHO）的合作机会，以支持各国做好充分准备，并推动长效艾滋病预防手段的可及性扩展。这一举措旨在强化全球公共卫生应对体系，尤其是针对中低收入国家的需求，通过技术转移、能力建设及供应链优化等途径，加快长效预防方案的落地与规模化应用。双方的合作重点在于应对实施层面的挑战，确保相关资源能够高效、公平地分配至最需要的人群，从而在更大范围内遏制HIV的传播。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU2324357040.USD","SG9999015952.SGD","LU0122379950.USD","IE00B19Z3581.USD","LU1585245621.USD","BIB","SG9999015978.USD","BK4588","BK4566","IBB","LU1057294990.SGD","LU2087621335.USD","LU2357627491.SGD","BK4532","LU1066051498.USD","TMED","LU0965509101.SGD","BK4550","TBXU","BK4568","LU0058720904.USD","BK4585","LU0965509283.SGD","BK4583","IE0002270589.USD","LU0234570918.USD","LU1778281490.HKD","SG9999015986.USD","LU0859254822.USD","LU1037948541.HKD","LU0965508806.USD","LU2468319806.SGD","LU1674673691.USD","LU2112291526.USD","LU0861579265.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","BBH","BK4139","LU0823416689.USD","LU0114720955.EUR","IE00B7SZLL34.SGD","LU1934455194.USD","LU0889565916.HKD","BK4578","BMED","IBBQ","LU1934455277.USD","LU0965509010.AUD","LU1839511570.USD","LU1023059063.AUD","LU1066053197.SGD","SG9999015945.SGD","LU1037948897.HKD","GILD","MEDI","IE00BSNM7G36.USD","LU0882574055.USD","LU1571399168.USD","LU1674673428.USD","LU1061106388.HKD","LU0109394709.USD","LU1430594728.SGD","LU2089984988.USD","LU0320765992.SGD","LU1934455863.HKD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623020","title":"吉利德科学公司高管在电话会议上表示，HIV药物市场的增长预计将在未来几个季度内回归至2%至3%的正常水平。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623020","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623020?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 23:11","pubTimestamp":1789485099,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4532","IBB","LU1037948897.HKD","SG9999015952.SGD","IBBQ","LU1674673691.USD","LU1037948541.HKD","BK4139","IE00B19Z3B42.SGD","LU1430594728.SGD","LU0965509283.SGD","IE00B7SZLL34.SGD","IE0002270589.USD","BBH","LU1585245621.USD","GILD","LU0122379950.USD","LU0965509010.AUD","LU0965509101.SGD","LU0058720904.USD","LU0114720955.EUR","LU0859254822.USD","LU1061106388.HKD","LU0234570918.USD","TMED","BK4550","LU0882574055.USD","LU1066051498.USD","LU0320765992.SGD","IE00BKVL7J92.USD","LU0889565916.HKD","LU2324357040.USD","BK4568","LU0289739699.SGD","LU2112291526.USD","LU1934455863.HKD","MEDI","BIB","BK4588","LU1066053197.SGD","SG9999015978.USD","LU1057294990.SGD","IE00B19Z3581.USD","LU1674673428.USD","TBXU","LU1934455277.USD","BMED","LU1839511570.USD","BK4566","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667062306","title":"吉利德与泛美卫生组织就拉丁美洲和加勒比地区艾滋病预防药物获取问题达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=2667062306","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667062306?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485029,"startTime":"0","endTime":"0","summary":"吉利德与泛美卫生组织就拉丁美洲和加勒比地区艾滋病预防药物获取问题达成一致路透9月15日-美国制药公司吉利德科学GILD.O周二表示，已与泛美卫生组织达成协议，将在拉丁美洲和加勒比地区扩大其艾滋病预防药物的可及性，以帮助这些地区遏制新发感染。吉利德公司指出，2010年至2024年间，拉丁美洲和加勒比地区的新发艾滋病毒感染病例增加了13%，并归因于艾滋病毒预防药物使用方面的缺口。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4T45714A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","BK4568","IE00B7SZLL34.SGD","TMED","LU1066053197.SGD","LU1674673691.USD","LU1037948897.HKD","LU0058720904.USD","LU1066051498.USD","LU1674673428.USD","SG9999015945.SGD","SG9999015952.SGD","LU0320765992.SGD","LU0882574055.USD","LU1061106388.HKD","LU1839511570.USD","SG9999015978.USD","LU1934455863.HKD","LU0122379950.USD","IE0002270589.USD","LU0889565916.HKD","MEDI","BMED","IBB","IE00BKVL7J92.USD","LU1585245621.USD","LU0965509283.SGD","LU0859254822.USD","BK4588","LU1934455277.USD","LU1430594728.SGD","LU2112291526.USD","LU2324357040.USD","BBH","BIB","BK4532","GILD","LU0289739699.SGD","LU0114720955.EUR","IE00B19Z3581.USD","BK4550","LU0234570918.USD","TBXU","IE00B19Z3B42.SGD","LU0965509010.AUD","LU0965509101.SGD","BK4139","IBBQ","BK4566","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159280995","title":"吉利德科学携手泛美卫生组织，加速拉美及加勒比地区HIV预防药物Lenacapavir的可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1159280995","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159280995?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485009,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）日前宣布，与泛美卫生组织（PAHO）达成一项战略合作。此番联手，旨在显著提升一年两针的HIV预防药物Lenacapavir在拉丁美洲及加勒比地区的可及性。双方的合作，将为该区域的高风险人群带来更便捷的预防选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU1023059063.AUD","IE00B7SZLL34.SGD","LU0859254822.USD","LU0965508806.USD","BIB","LU1674673428.USD","IBBQ","IE00B19Z3581.USD","LU1057294990.SGD","LU1037948541.HKD","LU0058720904.USD","LU0823416689.USD","LU1674673691.USD","LU1585245621.USD","LU1778281490.HKD","LU1839511570.USD","LU1934455194.USD","LU1037948897.HKD","LU2112291526.USD","SG9999015945.SGD","LU2324357040.USD","LU0965509283.SGD","LU1934455277.USD","SG9999015952.SGD","SG9999015986.USD","LU1571399168.USD","IE00B19Z3B42.SGD","BMED","LU0861579265.USD","BK4583","LU0965509010.AUD","LU0289739699.SGD","LU0114720955.EUR","IE00B3T34201.USD","LU0882574055.USD","BBH","BK4139","BK4566","BK4585","IE00BSNM7G36.USD","LU1061106388.HKD","IBB","LU1430594728.SGD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","TBXU","GILD","LU2357627491.SGD","SG9999015978.USD","LU0320765992.SGD","LU1066053197.SGD","BK4532","TMED","BK4578","LU1066051498.USD","LU0122379950.USD","LU1934455863.HKD","LU2468319806.SGD","BK4588","LU0965509101.SGD","LU0109394709.USD","LU0889565916.HKD","MEDI","LU2087621335.USD","LU2089984988.USD","BK4568","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153389014","title":"吉利德高管表示，未来几个季度HIV市场增长或将回归2%-3%常态水平","url":"https://stock-news.laohu8.com/highlight/detail?id=1153389014","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153389014?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 23:09","pubTimestamp":1789484948,"startTime":"0","endTime":"0","summary":"吉利德高管在电话会议中透露，该公司预计HIV治疗市场的增长势头将在未来几个季度内逐步趋于稳定，最终回到2%至3%的年增长区间。这一表态正值市场对HIV药物需求持续波动的关键节点。高管指出，当前的增长水平仍高于长期趋势，但随着时间推移，这种偏热的状态将逐渐降温。整个行业的扩张速度，预计将在近期内回落至更为可持续的轨道上。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","LU2087621335.USD","IBB","GILD","LU0882574055.USD","LU0058720904.USD","LU0861579265.USD","BK4550","BMED","IE00B19Z3581.USD","LU0122379950.USD","LU0234570918.USD","LU1585245621.USD","TBXU","LU1066053197.SGD","LU1839511570.USD","LU1934455194.USD","BK4566","BBH","LU0965509101.SGD","LU1061106388.HKD","LU0109394709.USD","LU1674673428.USD","IBBQ","IE00BKVL7J92.USD","LU1037948897.HKD","BK4139","LU2112291526.USD","LU2357627491.SGD","IE00BSNM7G36.USD","BK4532","LU0114720955.EUR","LU0289739699.SGD","MEDI","LU1037948541.HKD","BIB","LU1778281490.HKD","SG9999015986.USD","LU1571399168.USD","LU0965509283.SGD","SG9999015978.USD","IE0002270589.USD","BK4583","LU1430594728.SGD","LU1934455277.USD","LU2468319806.SGD","IE00B7SZLL34.SGD","LU0965509010.AUD","BK4585","LU2089984988.USD","LU0965508806.USD","IE00BZ1G4Q59.USD","BK4588","LU0823416689.USD","LU0859254822.USD","LU1066051498.USD","LU1934455863.HKD","LU1023059063.AUD","SG9999015945.SGD","LU1057294990.SGD","LU0889565916.HKD","SG9999015952.SGD","TMED","LU1674673691.USD","IE00B19Z3B42.SGD","IE00B3T34201.USD","BK4568","LU0320765992.SGD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131138631","title":"吉利德高管透露：周服HIV预防药物有望2027年第一季度上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1131138631","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131138631?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 23:05","pubTimestamp":1789484737,"startTime":"0","endTime":"0","summary":"吉利德科学高管在电话会议中表示，其每周口服HIV预防药物预计将于2027年第一季度正式推出。这一表态为公司抗艾药物管线注入了新的期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","LU2324357040.USD","LU0114720955.EUR","MEDI","SG9999015978.USD","LU1430594728.SGD","BIB","IE00B19Z3581.USD","LU1839511570.USD","GILD","LU2089984988.USD","LU1037948541.HKD","LU0965509101.SGD","LU0289739699.SGD","LU2112291526.USD","BK4566","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","IBBQ","LU1037948897.HKD","BK4578","SG9999015986.USD","LU0965508806.USD","LU2468319806.SGD","LU2087621335.USD","LU2357627491.SGD","BK4139","LU1023059063.AUD","LU0320765992.SGD","LU0882574055.USD","LU1934455277.USD","LU0861579265.USD","IE00BSNM7G36.USD","LU1585245621.USD","LU0122379950.USD","LU0234570918.USD","LU1778281490.HKD","BK4568","LU0889565916.HKD","LU0058720904.USD","LU1674673691.USD","BK4550","LU1061106388.HKD","LU1571399168.USD","BMED","LU1066053197.SGD","IE00B3T34201.USD","IE0002270589.USD","BBH","IE00BKVL7J92.USD","LU1934455863.HKD","BK4585","TBXU","TMED","IE00B19Z3B42.SGD","LU0965509283.SGD","LU0109394709.USD","LU0823416689.USD","LU1057294990.SGD","LU0859254822.USD","SG9999015945.SGD","BK4588","LU1674673428.USD","LU1934455194.USD","IBB","BK4532","LU0965509010.AUD","SG9999015952.SGD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136308873","title":"Assembly Biosciences有望获得高达2.8亿美元里程碑付款及美国境外特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1136308873","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136308873?lang=zh_cn&edition=fundamental","pubTime":"2026-09-09 04:02","pubTimestamp":1788897732,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前披露，其在海外市场具备资格获取最高达2.8亿美元的里程碑款项，外加相应特许权使用费收入。据悉，这家生物科技企业所预期的资金流入将源自美国以外地区。对Assembly Biosciences而言，这笔潜在收入不仅反映其管线资产的外部合作价值，也可能为其后续研发投入提供坚实支撑。市场人士认为，此类非美国市场的收益结构有助于分散地域风险，增强公司财务韧性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU0965509283.SGD","IE00B7SZLL34.SGD","IBB","LU1585245621.USD","IE00B3T34201.USD","MEDI","BMED","LU0234570918.USD","LU1037948897.HKD","LU2089984988.USD","TMED","LU0289739699.SGD","LU1430594728.SGD","LU2087621335.USD","BK4588","LU2468319806.SGD","LU1778281490.HKD","SG9999015952.SGD","LU1037948541.HKD","SG9999015986.USD","ASMB","LU0122379950.USD","BK4583","BK4585","IE00BKVL7J92.USD","BK4532","BK4139","BBH","LU2112291526.USD","BIB","TBXU","LU0823416689.USD","LU1066051498.USD","LU0058720904.USD","IE00BSNM7G36.USD","LU0109394709.USD","LU1934455863.HKD","SG9999015978.USD","IBBQ","LU0965508806.USD","LU2324357040.USD","BK4550","BK4568","LU0965509101.SGD","IE00BZ1G4Q59.USD","SG9999015945.SGD","LU1674673691.USD","BK4578","LU0861579265.USD","IE0002270589.USD","LU1061106388.HKD","IE00B19Z3581.USD","LU0889565916.HKD","LU1066053197.SGD","LU0859254822.USD","LU1934455194.USD","LU2357627491.SGD","LU1023059063.AUD","LU1674673428.USD","LU0114720955.EUR","BK4566","LU0965509010.AUD","LU1934455277.USD","LU0882574055.USD","GILD","LU1571399168.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154623157","title":"Assembly Biosciences旗下Gs-1179预计2026年底前将推进至生殖器疱疹二期临床试验阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=1154623157","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154623157?lang=zh_cn&edition=fundamental","pubTime":"2026-09-09 04:02","pubTimestamp":1788897731,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前宣布，其研发管线中的候选药物Gs-1179有望在2026年年底之前顺利迈入针对生殖器疱疹的二期临床试验阶段。生殖器疱疹作为一种常见的性传播感染疾病，全球患者群体庞大，对创新疗法的需求十分迫切。Assembly Biosciences正积极加速该药物的研发进程，以期尽早为患者带来新的治疗选择。业内分析人士指出，若Gs-1179能够顺利通过后续试验的严格考验，将可能重塑该适应症的市场格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU2087621335.USD","LU1839511570.USD","BK4578","LU0289739699.SGD","IE00B19Z3B42.SGD","IBB","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0882574055.USD","LU0058720904.USD","BMED","LU1585245621.USD","LU2112291526.USD","TMED","LU0859254822.USD","SG9999015978.USD","LU1066051498.USD","LU0965509010.AUD","LU1934455194.USD","GILD","LU0889565916.HKD","SG9999015986.USD","LU1061106388.HKD","LU0114720955.EUR","LU1934455863.HKD","LU1037948541.HKD","LU0320765992.SGD","BK4566","BK4550","BK4568","LU0861579265.USD","LU1674673691.USD","LU1023059063.AUD","SG9999015945.SGD","LU1057294990.SGD","SG9999015952.SGD","IBBQ","BIB","LU2357627491.SGD","LU1934455277.USD","TBXU","IE00B19Z3581.USD","LU0965509283.SGD","BK4532","LU0965508806.USD","LU1430594728.SGD","IE0002270589.USD","LU0109394709.USD","LU1571399168.USD","IE00B7SZLL34.SGD","LU2089984988.USD","BK4585","LU0234570918.USD","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU1674673428.USD","BK4139","BK4583","ASMB","IE00BSNM7G36.USD","MEDI","LU2468319806.SGD","LU0122379950.USD","LU0823416689.USD","LU2324357040.USD","BK4588","LU1037948897.HKD","LU0965509101.SGD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115029168","title":"Assembly Biosciences：吉利德独享HSV HPI项目临床开发与商业化权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1115029168","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115029168?lang=zh_cn&edition=fundamental","pubTime":"2026-09-09 04:01","pubTimestamp":1788897702,"startTime":"0","endTime":"0","summary":"Assembly Biosciences宣布，吉利德科学已保留其HSV HPI项目的独家临床开发及商业化权利。这一决定标志着双方合作进一步深化，吉利德将全权主导该项目的后续推进与市场布局。对于Assembly Biosciences而言，此举不仅明确了合作伙伴的战略优先级，也为其自身聚焦其他管线资源提供了更大灵活性。业内观察人士指出，HSV HPI项目的独家授权，反映了吉利德在抗病毒治疗领域持续加码的雄心，同时也凸显了该类创新疗法在未被满足的医疗需求中所蕴含的巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","BBH","BK4578","LU0114720955.EUR","LU0823416689.USD","IE00B19Z3581.USD","LU0861579265.USD","LU0889565916.HKD","LU1066053197.SGD","LU1430594728.SGD","LU1571399168.USD","SG9999015986.USD","LU0320765992.SGD","BK4583","LU1674673691.USD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU1934455863.HKD","LU2089984988.USD","LU1023059063.AUD","MEDI","LU0965508806.USD","LU0122379950.USD","ASMB","LU2324357040.USD","LU2357627491.SGD","TMED","LU0109394709.USD","IBB","LU1674673428.USD","LU1037948541.HKD","GILD","BMED","SG9999015952.SGD","IE00B7SZLL34.SGD","LU2468319806.SGD","LU1066051498.USD","IE0002270589.USD","LU0882574055.USD","LU1037948897.HKD","LU0859254822.USD","IBBQ","LU1839511570.USD","BK4568","IE00BSNM7G36.USD","LU1057294990.SGD","LU2112291526.USD","IE00B19Z3B42.SGD","BK4532","LU0965509010.AUD","BK4139","BK4585","BK4588","IE00B3T34201.USD","BIB","LU0058720904.USD","BK4550","LU0289739699.SGD","LU1934455194.USD","LU1934455277.USD","SG9999015945.SGD","BK4566","IE00BKVL7J92.USD","LU0965509101.SGD","LU2087621335.USD","SG9999015978.USD","LU1585245621.USD","TBXU","LU0234570918.USD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179230759","title":"Assembly Biosciences行使与吉利德关于HSV解旋酶-引物酶抑制剂项目的美国利润分成选择权","url":"https://stock-news.laohu8.com/highlight/detail?id=1179230759","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179230759?lang=zh_cn&edition=fundamental","pubTime":"2026-09-09 04:01","pubTimestamp":1788897669,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司已正式行使与吉利德科学就HSV解旋酶-引物酶抑制剂项目达成的美国利润分成选择权。这一战略举措标志着双方合作进入新阶段，有望加速该抗病毒疗法的临床开发与商业化进程。通过行使该选择权，Assembly Biosciences将能够分享该药物在美国市场的未来收益，同时借助吉利德在抗病毒领域的深厚积累与市场渠道，共同推进这一潜在重磅药物的落地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU0823416689.USD","BBH","LU1066053197.SGD","LU0234570918.USD","LU1571399168.USD","LU1839511570.USD","LU1934455277.USD","LU0965509010.AUD","SG9999015945.SGD","IBB","BK4585","LU1934455863.HKD","IE0002270589.USD","LU1778281490.HKD","LU0889565916.HKD","LU1057294990.SGD","LU1430594728.SGD","LU1061106388.HKD","LU2468319806.SGD","MEDI","LU0114720955.EUR","BK4139","BMED","LU0965509101.SGD","IE00B19Z3581.USD","BK4583","BK4568","LU1066051498.USD","LU1674673428.USD","TBXU","TMED","LU0861579265.USD","LU0965508806.USD","SG9999015952.SGD","LU1585245621.USD","LU0289739699.SGD","IBBQ","LU0859254822.USD","SG9999015978.USD","GILD","IE00BKVL7J92.USD","BK4550","ASMB","LU0058720904.USD","SG9999015986.USD","LU0122379950.USD","BK4588","IE00BSNM7G36.USD","LU1674673691.USD","BK4566","LU0320765992.SGD","IE00B7SZLL34.SGD","LU1037948541.HKD","LU2089984988.USD","LU2324357040.USD","BIB","BK4578","IE00B19Z3B42.SGD","IE00B3T34201.USD","LU0109394709.USD","LU0882574055.USD","LU1934455194.USD","LU2087621335.USD","BK4532","LU2357627491.SGD","LU1037948897.HKD","LU2112291526.USD","IE00BZ1G4Q59.USD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374570","title":"吉利德科学(GILD)股票9月8日盘中下跌3.26%：释放什么信号？","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374570","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374570?lang=zh_cn&edition=fundamental","pubTime":"2026-09-09 01:16","pubTimestamp":1788887780,"startTime":"0","endTime":"0","summary":"• 吉利德在经历了长达数月的持续上涨后，因获利回吐而出现回调。\n• 强劲的第二季度营收主要受其旗舰 HIV 和 Trodelvy 产品线的推动。\n• 分析师维持“买入”评级，平均目标价为 157.79 美元。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156554-market-movers-gild-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU2087621335.USD","BK4532","LU0861579265.USD","MEDI","TBXU","IE00B19Z3581.USD","LU1037948541.HKD","BK4568","BIB","IE00BSNM7G36.USD","LU1571399168.USD","LU0965508806.USD","LU0289739699.SGD","SG9999015986.USD","IBB","LU0965509101.SGD","BK4583","IE00BKVL7J92.USD","LU0114720955.EUR","LU0122379950.USD","IE00B3T34201.USD","TMED","SG9999015952.SGD","IE00BZ1G4Q59.USD","LU1674673691.USD","IBBQ","BMED","SG9999015945.SGD","LU0058720904.USD","LU0109394709.USD","LU1934455277.USD","SG9999015978.USD","BK4578","LU0320765992.SGD","LU1023059063.AUD","LU1674673428.USD","LU0882574055.USD","IE0002270589.USD","LU2324357040.USD","IE00B7SZLL34.SGD","LU2112291526.USD","LU0859254822.USD","GILD","LU0823416689.USD","LU1839511570.USD","BBH","BK4585","LU1778281490.HKD","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196773407","title":"异动解读｜吉利德科学盘中下跌3.18%，报148.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1196773407","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196773407?lang=zh_cn&edition=fundamental","pubTime":"2026-09-08 21:44","pubTimestamp":1788875062,"startTime":"0","endTime":"0","summary":"9月8日，吉利德科学盘中下跌3.18%，报148.27美元/股，成交额3905.71万美元。吉利德科学所在的生物科技行业中，个股普遍承压，其中安进跌6.86%，Moderna跌2.15%，艾伯维公司跌1.03%，Ionis Pharmaceuticals跌3.05%，PDS Biotechnology涨161.55%。吉利德科学是一家以研究为基础的生物制药公司，主要聚焦病毒性疾病、炎性和纤维化疾病及肿瘤学领域。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165523116","title":"异动解读｜吉利德科学盘前下跌3.47%，报146.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165523116","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165523116?lang=zh_cn&edition=fundamental","pubTime":"2026-09-08 21:29","pubTimestamp":1788874147,"startTime":"0","endTime":"0","summary":"9月8日，吉利德科学盘前下跌3.47%，报146.39美元/股，成交额163.33万美元。吉利德科学所在的生物科技行业中，个股普遍承压，其中Moderna涨0.31%，艾伯维跌1.70%，安进跌6.69%，再生元制药跌1.17%，福泰制药跌2.95%。吉利德科学是一家以研究为基础的生物制药公司，主要聚焦病毒性疾病、炎性和纤维化疾病及肿瘤学领域。近期公司在产品审批方面动作频繁，8月底HIV新药Bixlenvo获FDA批准，Trodelvy在欧盟及美国先后获批用于三阴性乳腺癌一线治疗。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036374","title":"美国食品药品监督管理局（FDA）批准吉利德治疗艾滋病的每日一次复方片剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036374","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036374?lang=zh_cn&edition=fundamental","pubTime":"2026-08-28 05:50","pubTimestamp":1787867453,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）批准吉利德治疗艾滋病的每日一次复方片剂路透8月27日-吉利德科学公司周四表示，美国食品和药物管理局已批准该公司研发的每日一次口服复方药GILD.O，用于治疗HIV病毒载量已降至极低水平的成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4S44O24V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","IBB","GILD","IE00B19Z3581.USD","IBBQ","IE00B3T34201.USD","LU1934455194.USD","BK4532","IE00B7SZLL34.SGD","LU0965509283.SGD","BIB","IE00BKVL7J92.USD","LU0114720955.EUR","BK4566","LU1571399168.USD","LU2468319806.SGD","IE0002270589.USD","BMED","MEDI","LU0889565916.HKD","SG9999015945.SGD","IE00BZ1G4Q59.USD","BK4139","LU1066053197.SGD","LU1934455277.USD","TMED","LU0861579265.USD","LU2112291526.USD","LU1061106388.HKD","LU0109394709.USD","SG9999015952.SGD","LU0965508806.USD","LU0823416689.USD","LU0965509101.SGD","BBH","LU2324357040.USD","LU1023059063.AUD","SG9999015986.USD","LU0058720904.USD","LU1778281490.HKD","TBXU","LU1037948541.HKD","LU0289739699.SGD","LU1037948897.HKD","SG9999015978.USD","BK4585","BK4568","LU1839511570.USD","LU1430594728.SGD","LU1674673691.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198194055","title":"美国FDA批准吉利德科学Bixlenvo™上市：每日单片方案为病毒学抑制HIV成人患者提供新选择，涵盖复杂治疗方案人群","url":"https://stock-news.laohu8.com/highlight/detail?id=1198194055","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198194055?lang=zh_cn&edition=fundamental","pubTime":"2026-08-28 05:49","pubTimestamp":1787867358,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局正式批准了吉利德科学旗下新药Bixlenvo。这款每日一次的单片制剂，专为病毒学抑制状态的HIV成人感染者设计——即便是那些正在接受复杂治疗方案的病患，也适用这一新选项。此项获批标志着HIV治疗领域又添一枚重要砝码。Bixlenvo以单片复方形式呈现，将给药频率与用药负担同步压缩，患者无需再面对繁琐的多药组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BBH","LU1934455277.USD","LU0289739699.SGD","LU2468319806.SGD","IE0002270589.USD","BK4583","TBXU","LU0058720904.USD","LU1571399168.USD","LU0859254822.USD","SG9999015978.USD","LU1430594728.SGD","LU2357627491.SGD","LU1585245621.USD","LU0861579265.USD","IE00B19Z3B42.SGD","LU1037948541.HKD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU0122379950.USD","LU0965509101.SGD","IE00BZ1G4Q59.USD","LU2089984988.USD","LU2087621335.USD","TMED","SG9999015986.USD","IE00BKVL7J92.USD","LU2112291526.USD","LU0889565916.HKD","LU1023059063.AUD","LU0882574055.USD","LU1674673428.USD","MEDI","LU0109394709.USD","LU1066053197.SGD","LU1839511570.USD","LU1061106388.HKD","SG9999015945.SGD","BK4578","GILD","IBBQ","LU0965509283.SGD","LU1674673691.USD","IBB","LU0114720955.EUR","LU0320765992.SGD","SG9999015952.SGD","IE00B7SZLL34.SGD","LU0965508806.USD","LU1778281490.HKD","LU1934455194.USD","LU0234570918.USD","BK4588","LU0823416689.USD","BIB","BK4550","BK4532","BK4585","BMED","LU0965509010.AUD","LU1037948897.HKD","IE00B3T34201.USD","LU1057294990.SGD","LU2324357040.USD","BK4139","BK4568","LU1934455863.HKD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186632498","title":"欧盟委员会扩大吉利德Trodelvy®在转移性三阴性乳腺癌一线治疗中的应用范围，覆盖所有PD-L1状态","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定，将吉利德科学（Gilead Sciences）旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域，且不再受限于患者的PD-L1表达状态。这一举措意味着，无论生物标志物检测结果如何，符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择，也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应，认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU1066053197.SGD","LU1778281490.HKD","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU0882574055.USD","LU0122379950.USD","IE00B19Z3B42.SGD","LU0058720904.USD","MEDI","GILD","LU2087621335.USD","TMED","LU1571399168.USD","LU1674673691.USD","BK4578","BK4588","BK4532","BBH","LU2357627491.SGD","BK4585","IE0002270589.USD","BIB","LU1430594728.SGD","LU0320765992.SGD","LU1037948541.HKD","LU1934455277.USD","LU0965509283.SGD","LU2089984988.USD","IE00BZ1G4Q59.USD","BK4568","LU0114720955.EUR","LU1057294990.SGD","LU1839511570.USD","LU1066051498.USD","LU0289739699.SGD","LU1934455863.HKD","LU2112291526.USD","LU0859254822.USD","LU0965509101.SGD","LU0234570918.USD","LU1061106388.HKD","SG9999015986.USD","SG9999015945.SGD","IE00B7SZLL34.SGD","LU0823416689.USD","BK4566","LU0861579265.USD","SG9999015952.SGD","TBXU","LU0965509010.AUD","IE00B3T34201.USD","LU0889565916.HKD","LU2468319806.SGD","LU0965508806.USD","IBBQ","BK4583","IBB","SG9999015978.USD","LU1585245621.USD","LU2324357040.USD","LU1023059063.AUD","LU1037948897.HKD","LU1934455194.USD","BK4139","LU0109394709.USD","IE00BSNM7G36.USD","BK4550","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193380081","title":"吉利德科学：欧盟批准Trodelvy联合Keytruda用于一线PD-L1阳性转移性三阴性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193380081","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193380081?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567533,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布，欧盟已正式授予其抗体药物偶联物Trodelvy与默沙东的Keytruda联合用药方案的上市许可。这一批准针对的是既往未经治疗的PD-L1阳性转移性三阴性乳腺癌患者群体。此项授权标志着该联合疗法在欧盟地区的临床可及性迈出关键一步，为这类侵袭性强、治疗选择有限的乳腺癌亚型患者提供了新的一线治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","LU1057294990.SGD","IE00BSNM7G36.USD","BK4139","LU2087621335.USD","BK4566","IE00B19Z3581.USD","BK4578","BK4588","BBH","LU2468319806.SGD","LU0965508806.USD","IE00B3T34201.USD","LU1934455863.HKD","LU0122379950.USD","LU1934455194.USD","LU1674673691.USD","LU1430594728.SGD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0823416689.USD","LU1023059063.AUD","LU1066053197.SGD","LU0889565916.HKD","LU0965509010.AUD","LU1066051498.USD","TMED","BK4532","LU0109394709.USD","LU0861579265.USD","LU2089984988.USD","LU2112291526.USD","LU0289739699.SGD","LU0114720955.EUR","BK4568","LU1778281490.HKD","IE00B7SZLL34.SGD","LU0234570918.USD","LU1674673428.USD","IE0002270589.USD","LU1585245621.USD","LU0965509283.SGD","LU1037948897.HKD","LU2357627491.SGD","LU0320765992.SGD","SG9999015952.SGD","LU1571399168.USD","IBBQ","BK4550","BIB","SG9999015945.SGD","GILD","LU0058720904.USD","MEDI","BK4585","LU1037948541.HKD","TBXU","LU0965509101.SGD","LU0859254822.USD","LU0882574055.USD","IBB","LU1061106388.HKD","SG9999015978.USD","BK4583","LU1839511570.USD","LU2324357040.USD","IE00BZ1G4Q59.USD","BMED","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170485794","title":"异动解读｜吉利德科学盘中上涨3.07%，78亿美元收购Arcellx叠加Q2业绩超预期持续推升股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1170485794","media":"行情直击","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170485794?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 23:46","pubTimestamp":1787327199,"startTime":"0","endTime":"0","summary":"8月21日，吉利德科学盘中上涨3.07%，报147.85美元/股，成交额2.28亿美元。消息面上，吉利德科学于8月18日宣布将以78亿美元股权价值收购癌症疗法研发公司Arcellx，每股支付115美元现金外加每股5美元或有价值权，较Arcellx上一交易日收盘价溢价87%，市场将此视为公司进一步强化肿瘤学管线的重大战略举措，收购消息公布以来持续提振市场情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"吉利德科学盘中上涨，78亿收购叠加业绩超预期","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":159,"code":"91000000","status":"200"}]}}